We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Ixabepilone (epothilone B analogue BMS-247550) is active in chemotherapy-naive patients with hormone-refractory prostate cancer: a Southwest Oncology Group trial S0111.
- Authors
Hussain, Maha; Tangen, Catherine M; Lara, Primo N, Jr; Vaishampayan, Ulka N; Petrylak, Daniel P; Colevas, A Dimitrios; Sakr, Wael A; Crawford, E David; Southwest Oncology Group
- Abstract
The epothilones are a new class of tubulin-polymerizing agents with activity in taxane-sensitive and resistant tumor models. We evaluated ixabepilone (BMS-247550) in patients with metastatic hormone-refractory prostate cancer (HRPC).
- Publication
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2005, Vol 23, Issue 34, p8724
- ISSN
0732-183X
- Publication type
Journal Article
- DOI
10.1200/JCO.2005.02.4448